Cargando…

Loss of E-cadherin and epithelial to mesenchymal transition is not required for cell motility in tissues or for metastasis

Loss of E-cadherin has been long considered to be a major hallmark of epithelial-mesenchymal transition (EMT) and has been reported in various cancers. P120 catenin regulates E-cadherin stability on the cell surface and also plays a role in intracellular signaling by modulating nuclear transcription...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiang, Huang, Huocong, Remmers, Neeley, Hollingsworth, Michael A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2014
Materias:	Short Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292045/ https://www.ncbi.nlm.nih.gov/pubmed/25610757 http://dx.doi.org/10.4161/21688362.2014.969112

Ejemplares similares

N-Cadherin Extracellular Repeat 4 Mediates Epithelial to Mesenchymal Transition and Increased Motility
por: Kim, Jae-Beom, et al.
Publicado: (2000)

E-cadherin on epithelial–mesenchymal transition in thyroid cancer
por: Zhu, Xiaoyu, et al.
Publicado: (2021)

VEGF Mediates Tumor Growth and Metastasis by Affecting the Expression of E-Cadherin and N-Cadherin Promoting Epithelial to Mesenchymal Transition in Gastric Cancer
por: Zhang, Yue, et al.
Publicado: (2023)

The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
por: Loh, Chin-Yap, et al.
Publicado: (2019)

PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma
por: Zhou, Wuhua, et al.
Publicado: (2018)

DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells
por: Zhang, Lili, et al.
Publicado: (2018)

Loss of E-cadherin expression is not a prerequisite for c-erbB2-induced epithelial-mesenchymal transition
por: NILSSON, GISELA M.A., et al.
Publicado: (2014)

Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression
por: Myong, Na-Hye
Publicado: (2012)

Correction to: PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma
por: Zhou, Wuhua, et al.
Publicado: (2018)

Correction to: PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma
por: Zhou, Wuhua, et al.
Publicado: (2019)

Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts
por: Tisza, Michael J., et al.
Publicado: (2016)

Loss and Recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation Is a Mechanism Involved in Epithelial-Mesenchymal-Epithelial Transitions
por: Pinho, Salomé S., et al.
Publicado: (2012)

Roles of E-cadherin and Noncoding RNAs in the Epithelial–mesenchymal Transition and Progression in Gastric Cancer
por: Bure, Irina V., et al.
Publicado: (2019)

Significance of E-cadherin and Vimentin as epithelial-mesenchymal transition markers in colorectal carcinoma prognosis
por: Niknami, Zohreh, et al.
Publicado: (2020)

BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer
por: Shu, Jie, et al.
Publicado: (2019)

E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition
por: Chen, Augustine, et al.
Publicado: (2014)

DE-Cadherin Is Required for Intercellular Motility during Drosophila Oogenesis
por: Niewiadomska, Paulina, et al.
Publicado: (1999)

Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition
por: Chao, Yvonne L, et al.
Publicado: (2010)

Mesenchymal-to-epithelial transitions require tissue-specific interactions with distinct laminins
por: Pitsidianaki, Ioanna, et al.
Publicado: (2021)

Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)

Role of N-Cadherin in Epithelial-to-Mesenchymal Transition and Chemosensitivity of Colon Carcinoma Cells
por: Skarkova, Veronika, et al.
Publicado: (2022)

Role of epithelial-mesenchymal transition markers E-cadherin, N-cadherin, β-catenin and ZEB2 in laryngeal squamous cell carcinoma
por: Zhu, Guang-Jie, et al.
Publicado: (2018)

miR-25 mediates metastasis and epithelial–mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling
por: Liu, Bing, et al.
Publicado: (2019)

TdIF1-LSD1 Axis Regulates Epithelial—Mesenchymal Transition and Metastasis via Histone Demethylation of E-Cadherin Promoter in Lung Cancer
por: Liu, Qi, et al.
Publicado: (2021)

Histone acetyltransferase CSRP2BP promotes the epithelial–mesenchymal transition and metastasis of cervical cancer cells by activating N-cadherin
por: Yang, Xiaohui, et al.
Publicado: (2023)

Partial epithelial–mesenchymal transition during enamel development
por: Bazina, Fayrouz, et al.
Publicado: (2022)

MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer
por: Wu, Chia-Lun, et al.
Publicado: (2016)

SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells
por: Sun, Ting, et al.
Publicado: (2018)

Oncogenic effect of PHLDB2 is associated with epithelial–mesenchymal transition and E-cadherin regulation in colorectal cancer
por: Chen, Geng, et al.
Publicado: (2019)

NUBPL, a novel metastasis‐related gene, promotes colorectal carcinoma cell motility by inducing epithelial–mesenchymal transition
por: Wang, Yuhui, et al.
Publicado: (2017)

E-cadherin is required for metastasis in multiple models of breast cancer
por: Padmanaban, Veena, et al.
Publicado: (2019)

Distinct Mesenchymal Alterations in N-Cadherin and E-Cadherin Positive Primary Renal Epithelial Cells
por: Keller, Christof, et al.
Publicado: (2012)

The synovial cadherin (cadherin-11) promotes intercellular motility
por: Kiener, Hans P, et al.
Publicado: (2007)

Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer
por: Zhang, Hui, et al.
Publicado: (2018)

Porcine pancreatic ductal epithelial cells transformed with KRAS(G12D) and SV40T are tumorigenic
por: Bailey, Katie L., et al.
Publicado: (2021)

Epithelial–mesenchymal transition in non-targeted lung tissues of Kunming mice exposed to X-rays is suppressed by celecoxib
por: Hu, Wentao, et al.
Publicado: (2018)

SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial‐mesenchymal transition
por: Zhang, Yuanping, et al.
Publicado: (2021)

MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT)
por: Ding, Xiang-Ming
Publicado: (2014)

Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition
por: An, Hanbing, et al.
Publicado: (2015)

Epithelial-mesenchymal transition in keloid tissue
por: Yang, Chae-Eun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c92rfb6d81qb09br6cf49a6v8e